These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35290461)

  • 1. School-Based Malaria Screening and Treatment Reduces Plasmodium falciparum Infection and Anemia Prevalence in Two Transmission Settings in Malawi.
    Cohee LM; Peterson I; Buchwald AG; Coalson JE; Valim C; Chilombe M; Ngwira A; Bauleni A; Schaffer-DeRoo S; Seydel KB; Wilson ML; Taylor TE; Mathanga DP; Laufer MK
    J Infect Dis; 2022 Aug; 226(1):138-146. PubMed ID: 35290461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.
    Halliday KE; Okello G; Turner EL; Njagi K; Mcharo C; Kengo J; Allen E; Dubeck MM; Jukes MC; Brooker SJ
    PLoS Med; 2014 Jan; 11(1):e1001594. PubMed ID: 24492859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. School-based screening and treatment may reduce P. falciparum transmission.
    Cohee LM; Valim C; Coalson JE; Nyambalo A; Chilombe M; Ngwira A; Bauleni A; Seydel KB; Wilson ML; Taylor TE; Mathanga DP; Laufer MK
    Sci Rep; 2021 Mar; 11(1):6905. PubMed ID: 33767384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and Risk Factors Associated with Polymerase Chain Reaction-Determined
    Mwaiswelo R; Ngasala B; Jovel I; Xu W; Larsson E; Malmberg M; Gil JP; Premji Z; Mmbando BP; Mårtensson A
    Am J Trop Med Hyg; 2019 May; 100(5):1179-1186. PubMed ID: 30860013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy.
    Aydin-Schmidt B; Mubi M; Morris U; Petzold M; Ngasala BE; Premji Z; Björkman A; Mårtensson A
    Malar J; 2013 Oct; 12():349. PubMed ID: 24079306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of an HRP-2/panLDH rapid diagnostic test to detect peripheral and placental Plasmodium falciparum infection in Papua New Guinean women with anaemia or suspected malaria.
    Umbers AJ; Unger HW; Rosanas-Urgell A; Wangnapi RA; Kattenberg JH; Jally S; Silim S; Lufele E; Karl S; Ome-Kaius M; Robinson LJ; Rogerson SJ; Mueller I
    Malar J; 2015 Oct; 14():412. PubMed ID: 26480941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal impact of asymptomatic malaria/HIV-1 co-infection on
    Roberds A; Kifude C; Oyieko J; Ocholla S; Mutunga J; Oullo D; Waga C; Li Z; Luckhart S; Stewart VA
    Front Cell Infect Microbiol; 2022; 12():934641. PubMed ID: 36189366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment.
    Omondi P; Burugu M; Matoke-Muhia D; Too E; Nambati EA; Chege W; Musyoka KB; Thiongo K; Otinga M; Muregi F; Kimani F
    Malar J; 2019 Dec; 18(1):398. PubMed ID: 31801562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.
    Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S
    Malar J; 2012 Dec; 11():434. PubMed ID: 23272998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.
    Roth JM; Sawa P; Omweri G; Osoti V; Makio N; Bradley J; Bousema T; Schallig HDFH; Mens PF
    Malar J; 2018 Jun; 17(1):223. PubMed ID: 29866116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in four malaria endemic states of India.
    Krishna S; Mishra S; Tiwari P; Vishwakarma AK; Khandai S; Shrivastava S; Verma AK; Tiwari S; Barman H; Jhariya S; Tiwari P; Tidgam AS; Varun BM; Singh S; Yerane N; Tembhurne CR; Mandavi PL; Tekam SS; Malik M; Behera KP; Jayswar H; Sonwani K; Diggikar MS; Pradhan MM; Khasotiya SS; Kumar A; Dhingra N; Bustos MDG; Christophel EM; Ringwald P; Kumari R; Shukla MM; Singh N; Das A; Bharti PK
    Malar J; 2021 May; 20(1):229. PubMed ID: 34020652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.
    Kern SE; Tiono AB; Makanga M; Gbadoé AD; Premji Z; Gaye O; Sagara I; Ubben D; Cousin M; Oladiran F; Sander O; Ogutu B
    Malar J; 2011 Jul; 10():210. PubMed ID: 21801345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
    Pembet Singana B; Casimiro PN; Matondo Diassivi B; Kobawila SC; Youndouka JM; Basco LK; Ringwald P; Briolant S; Ndounga M
    Malar J; 2022 May; 21(1):137. PubMed ID: 35501861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
    Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
    Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemether-Lumefantrine Efficacy for the Treatment of Uncomplicated
    Olivera MJ; Guerra AP; Cortes LJ; Horth RZ; Padilla J; Novoa J; Ade MP; Ljolje D; Lucchi NW; Marquiño W; Renteria M; Yurgaky W; Macedo de Oliveira A
    Am J Trop Med Hyg; 2020 May; 102(5):1056-1063. PubMed ID: 32100686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic recrudescence after artemether-lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis.
    Mumtaz R; Okell LC; Challenger JD
    Malar J; 2020 Dec; 19(1):453. PubMed ID: 33298080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia.
    Golassa L; Baliraine FN; Enweji N; Erko B; Swedberg G; Aseffa A
    BMC Infect Dis; 2015 Aug; 15():310. PubMed ID: 26242405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.